Albuterol Sulfate Syrup Recalled for Incomplete Stability Studies
Akorn, Inc. is recalling all lots of Albuterol Sulfate Syrup nationwide due to CGMP deviations. The firm went out of business and could not complete required stability studies to verify ongoing product safety and effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II precautionary recall with no reported illnesses or injuries and no confirmed product defects. The issue is incomplete stability studies due to firm closure, making this a compliance matter rather than an identified product hazard. The theoretical nature of the hazard and lack of reported harm place this at Moderate severity.
Plain-English summary
Akorn, Inc. is recalling all lots of Albuterol Sulfate Syrup (2 mg base, 16 fl oz per bottle) distributed nationwide in the USA and Puerto Rico. The recall affects all NDC codes for this medication.
The recall was initiated due to CGMP (Current Good Manufacturing Practice) deviations. Specifically, the firm went out of business and could no longer continue ongoing stability studies required to verify that the product remains safe and effective throughout its shelf life.
Patients using this medication should not stop their treatment without consulting their healthcare provider. Those who have this product should speak with their pharmacist or physician about whether they have affected stock and what alternatives may be available.
Healthcare providers and pharmacists with questions should contact the recalling firm or the FDA.
The recalled product
- Product
- Albuterol Sulfate Syrup, 2mg (base), 16 fl oz (473 mL) per bottle, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Respiratory
- Hazard
- stability-unverified
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27